MicroCures

MicroCures is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of fibrosis. Read more

MicroCures

MicroCures is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of fibrosis. Read more

Derek Proudian's photo - Chairman & CEO of MicroCures

Chairman & CEO

Derek Proudian

CEO Approval Rating

90/100

Founded:

2011

Status:

PrivateIndependent Company

MICROCURES TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

MediciNova is MicroCures's #1 competitor. MediciNova was founded in La Jolla, California} in 2000. Like MicroCures, MediciNova also competes in the Biotechnology industry. Compared to MicroCures, MediciNova generates $4M more revenue.

Acceleron is one of MicroCures's top competitors. Acceleron was founded in 2003 in Cambridge, Massachusetts. Like MicroCures, Acceleron also operates in the Biotechnology industry. Acceleron generates $90.5M more revenue than MicroCures.

Momenta Pharmaceuticals, Inc. is a top competitor of MicroCures. Momenta Pharmaceuticals, Inc. was founded in 2001, and is headquartered in Cambridge, Massachusetts. Like MicroCures, Momenta Pharmaceuticals, Inc. also competes in the Biotechnology field. Momenta Pharmaceuticals, Inc. generates $25.1M more revenue vs. MicroCures.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is FibroGen a competitor of MicroCures?

MicroCures Acquisitions

No recent acquisitions found related to MicroCures

MicroCures Funding History

$1.5M

Since MicroCures was founded in 2011, it has participated in 1 round of funding. In total MicroCures has raised $1.5M. MicroCures' funding round was on Jan 2020 for a total of $1.5M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Grant
Jan 2020
$1.5M

National Institutes of Health

Since MicroCures was founded in 2011, it has participated in 1 round of funding. In total MicroCures has raised $1.5M. MicroCures' funding round was on Jan 2020 for a total of $1.5M

MicroCures Investments

No recent investments found related to MicroCures

MicroCures News

January 8, 2020BioSpace

MicroCures Awarded $1.5M SBIR Grant To Support Development of Novel Therapeutic Platform for Accelerated Tissue Repair

MicroCures, a biopharmaceutical company developing novel therapeutics that harness the body’s innate ... See more »

MicroCures Press Releases

MicroCures Videos

Social Media

MicroCures Headquarters

Forchheimer Building Suite 726

New York, New York10461

Driving Directions »

Trending Companies

MicroCures Summary

ABOUT

Overview

MicroCures is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of fibrosis. MicroCures was founded in 2011. MicroCures' headquarters is located in New York, New York, USA 10461. It has raised 1.5M in 1 round....

CEO

MicroCures's Chairman & CEO, Derek Proudian, currently has an approval rating of 90%. MicroCures's primary competitors are MediciNova, Acceleron & Momenta Pharmaceuticals, Inc..

Website

microcures.com

Frequently Asked Questions about MicroCures

  1. When was MicroCures founded?

    MicroCures was founded in 2011
  2. Who is MicroCures's CEO?

    MicroCures's CEO is Derek Proudian
  3. How much revenue does MicroCures generate?

    MicroCures generates $2M in revenue
  4. How much funding does MicroCures have?

    MicroCures has historically raised $1.5M in funding
  1. Where is MicroCures's headquarters?

    MicroCures's headquarters is in New York New York, USA
  2. How many employees does MicroCures have?

    MicroCures has 10 employees
  3. What sector does MicroCures operate in?

    MicroCures is in Biotechnology, Pharmaceuticals
  4. Who are MicroCures's competitors?

    MicroCures's top competitors are MediciNova, Acceleron, Momenta Pharmaceuticals, Inc.